Stopping steroids in polymyalgia rheumatica and giant cell arteritis.
作者信息
Kyle V, Hazelman B L
机构信息
Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge.
出版信息
BMJ. 1990 Feb 10;300(6721):344-5. doi: 10.1136/bmj.300.6721.344.
Abstract
摘要
相似文献
1
Stopping steroids in polymyalgia rheumatica and giant cell arteritis.
BMJ. 1990 Feb 10;300(6721):344-5. doi: 10.1136/bmj.300.6721.344.
2
3
[Lower steroid dosage over a short time is preferable in polymyalgia rheumatica and temporal arteritis].
Lakartidningen. 1991 Apr 24;88(17):1577-9.
4
5
6
A district audit on the management of polymyalgia rheumatica and giant cell arteritis.
Br J Rheumatol. 1994 Feb;33(2):152-6. doi: 10.1093/rheumatology/33.2.152.
7
Information from your family doctor. Polymyalgia rheumatica and giant cell arteritis.
Am Fam Physician. 2013 Nov 15;88(10):Online.
8
PMR and GCA: steroids or bust.
Int J Clin Pract. 2012 Jun;66(6):524-7. doi: 10.1111/j.1742-1241.2012.02914.x.
9
Discontinuation of therapies in polymyalgia rheumatica and giant cell arteritis.
Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S86-92. Epub 2013 Oct 4.
10
The management of polymyalgia rheumatica and giant cell arteritis.
Drug Ther Bull. 1993 Aug 16;31(17):65-8.
引用本文的文献
1
Clinical features of polymyalgia rheumatica and giant cell arteritis.
Nat Rev Rheumatol. 2012 Sep;8(9):509-21. doi: 10.1038/nrrheum.2012.97. Epub 2012 Jul 24.
2
Optimal management of giant cell arteritis and polymyalgia rheumatica.
Ther Clin Risk Manag. 2012;8:173-9. doi: 10.2147/TCRM.S13088. Epub 2012 Apr 5.
3
Anti-TNF therapy for polymyalgia rheumatica: report of 99 cases and review of the literature.
Clin Rheumatol. 2012 Mar;31(3):575-9. doi: 10.1007/s10067-011-1914-z. Epub 2012 Jan 11.
4
Giant cell arteritis and mortality.
J Gerontol A Biol Sci Med Sci. 2009 Mar;64(3):365-9. doi: 10.1093/gerona/gln030. Epub 2009 Feb 4.
5
[Glucocorticoids: importance in the treatment of vasculitis].
Z Rheumatol. 2005 Apr;64(3):155-61. doi: 10.1007/s00393-005-0717-5.
6
Epidemiology and optimal management of polymyalgia rheumatica.
Drugs Aging. 1998 Aug;13(2):109-18. doi: 10.2165/00002512-199813020-00003.
7
Interleukin-6 in clinical relapses of polymyalgia rheumatica and giant cell arteritis.
Ann Rheum Dis. 1996 Jun;55(6):403-4. doi: 10.1136/ard.55.6.403-b.
8
Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
Ann Rheum Dis. 1995 Aug;54(8):640-4. doi: 10.1136/ard.54.8.640.
9
The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica.
Clin Rheumatol. 1995 May;14(3):315-8. doi: 10.1007/BF02208345.
10
Corticosteroids and osteoporosis.
Thorax. 1990 Aug;45(8):573-8. doi: 10.1136/thx.45.8.573.
本文引用的文献
1
Prognosis in the anarthritic rheumatoid syndrome.
Br Med J. 1963 Feb 23;1(5329):513-8. doi: 10.1136/bmj.1.5329.513.
2
Myalgic syndrome with constitutional effects; polymyalgia rheumatica.
Ann Rheum Dis. 1957 Jun;16(2):230-7. doi: 10.1136/ard.16.2.230.
3
Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy.
J Am Med Assoc. 1957 Mar 9;163(10):821-7. doi: 10.1001/jama.1957.02970450023007.
4
Prognosis and management of polymyalgia rheumatica.
Ann Rheum Dis. 1981 Feb;40(1):1-5. doi: 10.1136/ard.40.1.1.
5
Treatment of polymyalgia rheumatica.
Arthritis Rheum. 1982 Jan;25(1):120. doi: 10.1002/art.1780250124.
6
Giant cell (cranial) arteritis: a clinical review.
Am Heart J. 1980 Jul;100(1):99-105. doi: 10.1016/0002-8703(80)90285-9.
7
Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.
Ann Intern Med. 1982 Nov;97(5):672-80. doi: 10.7326/0003-4819-97-5-672.
8
Polymyalgia rheumatica and corticosteroids: how much for how long?
Ann Rheum Dis. 1983 Aug;42(4):374-8. doi: 10.1136/ard.42.4.374.
9
Prognosis in giant-cell arteritis.
Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):269-71. doi: 10.1136/bmj.282.6260.269.
10
Decrease of the OKT8 positive T cell subset in polymyalgia rheumatica. Lack of correlation with disease activity.
Arthritis Rheum. 1983 Dec;26(12):1472-80. doi: 10.1002/art.1780261209.
Zotero 插件